Study of the effect of concomitant food on the bioavailability of rifampicin, isoniazid and pyrazinamide.
about
Pharmacokinetics of rifampin and clarithromycin in patients treated for Mycobacterium ulcerans infection.Tuberculosis chemotherapy in the 21 century: Back to the basics.Impact of food on the pharmacokinetics of first-line anti-TB drugs in treatment-naive TB patients: a randomized cross-over trial.Pharmacokinetics of rifampin in Peruvian tuberculosis patients with and without comorbid diabetes or HIVRifapentine for the treatment of pulmonary tuberculosis.Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorptionPharmacokinetics of first-line tuberculosis drugs in Tanzanian patients.Don't forget the bigger picture: the impact of societal issues on a community-based TB programme, Swaziland.Influence of Food on Paediatric Gastrointestinal Drug Absorption Following Oral Administration: A Review.Significance of nutrition in pulmonary tuberculosis.Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.The challenges of pharmacokinetic variability of first-line anti-TB drugs.[Antibiotic stewardship and Staphylococcus aureus Bacteremia].Population pharmacokinetics of rifampicin and 25-deacetyl-rifampicin in healthy Asian adults.Tuberculosis and nutrition.Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs.Investigation of the effects of concomitant caffeine administration on the metabolic disposition of pyrazinamide in rats.Administration of anti-tuberculosis drugs through patient empowerment.Correlation between the systemic clearance of drugs and their food effects in humans.
P2860
Q34108761-1990DAE5-68FD-462F-B1E2-9A8B164B6967Q35183890-C79D36D0-23DC-4A7E-86EE-366E1F420AF9Q35867681-9BD08F6C-FE73-4761-AFBC-7E5BED6357F0Q35941434-2EE1B38D-A272-4E25-8D67-F1257446B48BQ36643657-364B8A32-2C66-4300-87FF-9E407CF7AA95Q36702972-CDFDF8EE-9B8B-4B64-8A7D-C3731DC61ADAQ36969720-579B1569-E0A8-4F7A-8DB9-1B6EC3048A4FQ37025872-8189BB84-CD84-49F5-9108-FF148525EFD6Q37055903-A5BE68E6-FA1E-4DB7-8FC4-AE9953B83D87Q38219137-A5335D8C-A365-4E02-B7BE-2AC18551DA33Q38865905-DAEBCD10-5B80-4A86-B8A7-2A94B82EBF44Q38977166-F6140A42-9535-4B6D-A67B-7CA0C1C1E68DQ40264352-936C666A-0A8D-41FA-BD70-5A44CE2E26EEQ40571190-9368A001-0B78-40A1-B368-933071A97EABQ42270487-A2519B40-8BA5-4D09-AD32-35441D340B61Q43060441-75127474-3ECF-479C-A400-B7BEA427BBEBQ44063003-A6B6DA33-ABAF-427A-A5B1-886466DC5D21Q46193291-AF8C985E-9A3A-4551-A17E-21225A455F57Q49145146-5054BC78-A86A-48AF-8BE6-8A14E3C09442
P2860
Study of the effect of concomitant food on the bioavailability of rifampicin, isoniazid and pyrazinamide.
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Study of the effect of concomi ...... n, isoniazid and pyrazinamide.
@ast
Study of the effect of concomi ...... n, isoniazid and pyrazinamide.
@en
Study of the effect of concomi ...... n, isoniazid and pyrazinamide.
@nl
type
label
Study of the effect of concomi ...... n, isoniazid and pyrazinamide.
@ast
Study of the effect of concomi ...... n, isoniazid and pyrazinamide.
@en
Study of the effect of concomi ...... n, isoniazid and pyrazinamide.
@nl
prefLabel
Study of the effect of concomi ...... n, isoniazid and pyrazinamide.
@ast
Study of the effect of concomi ...... n, isoniazid and pyrazinamide.
@en
Study of the effect of concomi ...... n, isoniazid and pyrazinamide.
@nl
P1476
Study of the effect of concomi ...... n, isoniazid and pyrazinamide.
@en
P304
P356
10.1016/0962-8479(95)90551-0
P577
1995-04-01T00:00:00Z